跳至主要内容
临床试验/KCT0007057
KCT0007057已完成未知

Pragmatic randomized controlled trial of pharmacopuncture therapy for cervical disc herniation: A pilot study

Jaseng Hospital of Korean Medicine0 个研究点目标入组 84 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 69(Year)(—)
性别
All

入选标准

  • 1.Symptoms of cervical disc herniation for less than 12 months
  • 2.Numeric Rating Scale (NRS) of neck pain is more than 5
  • 3.Symptoms of neuromuscular disease in one or both upper limbs (pain, pull, numbness, sensory abnormalities, motor abnormalities)
  • 4.Discrimination findings above protusion, which can explain clinical symptoms on Cervical spine MRI or CT
  • 5.19-69 years old
  • 6.participants who agreed and wrote informed consents

排除标准

  • 1.Case of being diagnosed with a specific serious disease that may cause neck pain(Migration of cancer reaching to spine, acute fracture of spine, spine dislocation)
  • 2.Progressive neurologic deficits or severe neurologic deficits
  • 3.Cause of pain due to soft tissue disease, not the spine(Cancer, fibromyalgia, RA, goat, or etc.)
  • 4.Other chronic diseases(stroke, MI, kidney disease, diabetic neuropathy, dimentia, epilepsy, or etc.) that may interfere with the interpretation of therapeutic effects or outcomes
  • 5.Participants taking steroid, immunosuppressant, psychotropic medication, or taking other drugs that may affect outcomes
  • 6.Inappropriate or unsafe pharmacopuncture therapy; hemorrhagic disease, taking anticoagulant drug, or severe diabetes patients who are likely to be infected
  • 7.Participants who took NSAIDs or pharmacopuncture, acupuncture, physical therapy within 1 week
  • 8.Pregnant, planning to get pregnant or lactating women
  • 9.Participants who had undergone cervical surgery within 3 months
  • 10.Participants who had participated in other clinical trial within 1 month, had participated in other study within 6 months from the date of selection, or have plan for participation in other trial during follow up period of this trial
  • 11.Participants who can not write informed consent
  • 12.Participants who is difficult to participate in the trial according to investigator's decision

研究者

发起方
Jaseng Hospital of Korean Medicine

相似试验